Type 1 diabetes: lessons for other autoimmune diseases?

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Type 1 diabetes (T1D) exhibits characteristics of autoimmune diseases.
• Environmental factors play a crucial role in T1D development, offering insights into gene-environment interactions for other autoimmune conditions.
• Identifying at-risk individuals pre-clinically is essential for developing preventative strategies.

Purpose of the Study:

• To explore the potential of proinsulin peptides in inducing immune tolerance for Type 1 diabetes prevention.
• To translate findings from the non-obese diabetic (NOD) mouse model to human Type 1 diabetes immunotherapy.
• To identify strategies for optimizing insulin-specific immunotherapy for autoimmune diseases.

Main Methods:

• Utilizing the non-obese diabetic (NOD) mouse model to study autoimmune diabetes.
• Investigating the role of proinsulin as an initial target of autoimmunity.
• Conducting proof-of-principle studies with insulin and proinsulin peptides for immune tolerance induction.
• Initiating early human trials of insulin-specific immunotherapy.

Main Results:

• Evidence in NOD mice suggests proinsulin is an early target of autoimmune attack.
• Studies in NOD mice demonstrated that insulin and proinsulin peptides can induce immune tolerance and prevent diabetes.
• Initial human trials of insulin-specific immunotherapy show promising results and provide insights for optimization.

Conclusions:

• Type 1 diabetes shares autoimmune disease characteristics, highlighting the need for public health measures against pro-inflammatory environments.
• Proinsulin peptide immunotherapy, successful in NOD mice, shows promise for preventing T1D in at-risk humans.
• Optimized insulin-specific immunotherapy approaches may be applicable to a broader range of autoimmune diseases.